Picture of Neovacs SA logo

ALNEV Neovacs SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Neovacs Announces A Capital Rise Of EUR 2 Mln

Dec 24 (Reuters) - NEOVACS SA  ALNEV.PA :  
    * ANNOUNCED ON WEDNESDAY A CAPITAL RISE OF EUR 2 MILLION 
    * CAPITAL INCREASE THROUGH THE DRAWDOWN OF 1 TRANCHE OF
CONVERTIBLE BONDS (OCEANE-BSA), WITH A NOMINAL VALUE OF 1,000
000 €
    * ADDITIONAL DRAWDOWN OF 1 TRANCHE OF CONVERTIBLE
BONDS(ORNANE),
WITH A NOMINAL VALUE OF 1,000 000 €
    * NET PROCEEDS OF OPERATION (1,9 M€) WILL BE ALLOCATED, FOR
50%,
TO FINANCE KINOÏDE RESEARCH PROGRAMME ON ALLERGIES AND, FOR 50%,
TO STRENGTHEN INVESTMENT CAPACITIES IN PROMISING PROJECTS, BOTH
IN DEVELOPMENT OF DRUG CANDIDATES AND MEDICAL DEVICES

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nACT66595
    
 Further company coverage:  ALNEV.PA  
   
    
    

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))

Recent news on Neovacs SA

See all news